Zoetis, Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health technology. The firm operates through the United States and International geographical segments. The company was founded in 1952 and is headquartered in Parsippany, NJ.
Current Value
$176.421 Year Return
Current Value
$176.421 Year Return
Market Cap
$79.21B
P/E Ratio
33.01
1Y Stock Return
-1.77%
1Y Revenue Growth
9.33%
Dividend Yield
0.79%
Price to Book
15.1
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
IDXX | 46.69% | $34.09B | -12.85% | 0.00% |
QTWO | 40.13% | $6.02B | +186.81% | 0.00% |
MQ | 39.62% | $1.96B | -36.48% | 0.00% |
MCO | 39.59% | $84.94B | +28.86% | 0.70% |
EPR | 39.30% | $3.38B | -0.51% | 7.62% |
REXR | 39.12% | $9.55B | -8.36% | 3.81% |
AVNT | 38.13% | $4.56B | +44.78% | 2.08% |
VFC | 38.08% | $7.51B | +16.70% | 1.89% |
NOVT | 37.92% | $5.95B | +15.14% | 0.00% |
EEFT | 37.71% | $4.44B | +16.88% | 0.00% |
AQN | 37.53% | $3.79B | -20.96% | 8.21% |
CHDN | 37.50% | $10.20B | +15.49% | 0.28% |
YOU | 37.37% | $2.50B | +34.63% | 1.10% |
IQV | 37.33% | $34.73B | -7.77% | 0.00% |
TY | 37.10% | - | - | 3.32% |
WYNN | 37.07% | $10.02B | +5.05% | 1.10% |
EL | 36.93% | $23.26B | -46.08% | 4.10% |
NEOG | 36.92% | $3.27B | -8.60% | 0.00% |
KTB | 36.90% | $5.01B | +70.31% | 2.22% |
ACM | 36.79% | $14.59B | +25.28% | 0.81% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
MCY | 0.02% | $4.07B | +102.23% | 1.73% |
NHTC | -0.03% | $61.83M | +0.19% | 14.81% |
GL | 0.04% | $9.18B | -8.60% | 0.86% |
EQX | 0.10% | $2.50B | +11.59% | 0.00% |
CB | 0.16% | $114.43B | +26.00% | 1.24% |
ALL | 0.31% | $52.06B | +45.67% | 1.85% |
RDDT | -0.33% | $24.08B | +303.41% | 0.00% |
QNTM | 0.34% | $9.19M | -94.36% | 0.00% |
SYPR | 0.43% | $32.23M | -26.32% | 0.00% |
MUFG | -0.47% | $138.35B | +39.37% | 1.09% |
HRTG | 0.60% | $371.89M | +58.22% | 0.00% |
MSDL | -0.63% | $1.83B | +0.66% | 7.26% |
GALT | 0.65% | $172.91M | +41.28% | 0.00% |
NTIC | 0.86% | $132.27M | +24.98% | 2.02% |
MKL | 0.91% | $21.48B | +16.38% | 0.00% |
WM | 0.98% | $87.92B | +27.58% | 1.34% |
SCKT | 1.01% | $10.88M | +15.32% | 0.00% |
RGR | 1.02% | $642.75M | -15.87% | 1.81% |
DELL | -1.02% | $99.00B | +84.60% | 1.24% |
THG | 1.06% | $5.88B | +36.24% | 2.08% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
HUSA | -37.35% | $16.69M | -11.56% | 0.00% |
LPLA | -11.41% | $23.55B | +38.13% | 0.38% |
VZIO | -10.95% | $2.29B | +67.76% | 0.00% |
QTTB | -9.93% | $354.34M | +188.64% | 0.00% |
PGR | -9.90% | $149.10B | +57.29% | 0.45% |
EDR | -9.65% | $9.01B | +19.26% | 0.82% |
NNE | -8.80% | $833.66M | +531.50% | 0.00% |
VIST | -8.16% | $4.75B | +67.10% | 0.00% |
CLLS | -6.98% | $141.30M | -30.99% | 0.00% |
BELFB | -6.44% | $903.17M | +35.81% | 0.38% |
CFLT | -6.23% | $9.28B | +49.05% | 0.00% |
CIG.C | -6.22% | $2.48B | -3.55% | 0.00% |
VSTS | -5.87% | $1.76B | -18.18% | 1.04% |
DK | -5.59% | $1.14B | -34.04% | 5.64% |
CBOE | -5.43% | $21.46B | +15.84% | 1.11% |
TXO | -4.82% | $737.26M | -1.80% | 13.22% |
VHC | -4.78% | $19.06M | -38.36% | 0.00% |
STG | -4.59% | $35.67M | +7.92% | 0.00% |
MANU | -4.54% | $2.88B | -9.41% | 0.00% |
DNTH | -4.53% | $659.13M | +93.65% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
PAWZ | 51.82% | $65.72M | 0.5% |
RSPH | 49.75% | $885.96M | 0.4% |
MOAT | 48.11% | $15.73B | 0.46% |
FXH | 47.81% | $1.15B | 0.62% |
REET | 47.50% | $3.83B | 0.14% |
RWO | 46.66% | $1.18B | 0.5% |
DFGR | 46.43% | $2.09B | 0.22% |
XPH | 46.02% | $157.87M | 0.35% |
VHT | 45.71% | $17.06B | 0.1% |
FHLC | 45.66% | $2.73B | 0.084% |
INDS | 44.92% | $178.70M | 0.55% |
XLV | 44.85% | $38.41B | 0.09% |
FRI | 44.78% | $181.98M | 0.5% |
MOO | 44.58% | $620.40M | 0.53% |
IYH | 44.51% | $3.19B | 0.39% |
IHI | 44.50% | $4.91B | 0.4% |
VBK | 44.10% | $19.31B | 0.07% |
XLRE | 44.07% | $7.46B | 0.09% |
FREL | 44.05% | $1.06B | 0.084% |
IWS | 44.05% | $13.85B | 0.23% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
AGZD | 0.07% | $142.76M | 0.23% |
CMDY | 0.14% | $279.14M | 0.28% |
CPER | 0.18% | $159.52M | 0.97% |
CANE | 0.37% | $17.72M | 0.29% |
BILZ | 0.58% | $563.02M | 0.14% |
ULST | -0.58% | $535.47M | 0.2% |
BCI | -0.59% | $1.20B | 0.26% |
BCD | -1.48% | $245.02M | 0.3% |
WEAT | 1.77% | $120.27M | 0.28% |
TBLL | 1.82% | $1.92B | 0.08% |
GCC | -2.54% | $133.23M | 0.55% |
IBTF | 2.95% | $2.05B | 0.07% |
IBHD | -2.96% | $327.80M | 0.35% |
TBIL | 3.00% | $4.38B | 0.15% |
JBBB | 3.21% | $1.26B | 0.49% |
IBTE | -3.24% | $1.70B | 0.07% |
DBB | -3.25% | $126.37M | 0.77% |
TDTT | 3.51% | $1.84B | 0.18% |
CLOI | -3.57% | $715.40M | 0.4% |
YEAR | 3.72% | $1.13B | 0.25% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
VIXY | -29.08% | $195.31M | 0.85% |
BTAL | -28.68% | $388.04M | 1.43% |
USDU | -27.71% | $201.97M | 0.5% |
UUP | -22.75% | $309.25M | 0.77% |
HIGH | -17.81% | $302.78M | 0.51% |
EQLS | -17.61% | $76.08M | 1% |
TAIL | -17.33% | $67.98M | 0.59% |
USCI | -13.32% | $185.47M | 1.07% |
PDBC | -12.06% | $4.40B | 0.59% |
TPMN | -11.48% | $40.60M | 0.65% |
DBA | -10.57% | $755.88M | 0.93% |
DBE | -10.30% | $50.13M | 0.77% |
KMLM | -9.96% | $353.87M | 0.9% |
DBO | -9.86% | $217.57M | 0.77% |
SOYB | -8.77% | $27.32M | 0.22% |
CTA | -7.58% | $350.27M | 0.78% |
CORN | -6.04% | $61.12M | 0.2% |
GSG | -5.67% | $914.42M | 0.75% |
BOXX | -4.99% | $4.43B | 0.1949% |
COMT | -4.83% | $829.06M | 0.48% |
SeekingAlpha
Zoetis Inc. (NYSE:ZTS) Jefferies London Healthcare Conference November 20, 2024 10:00 AM ETCompany ParticipantsWetteny Joseph - CFOConference Call...
Yahoo
PARSIPPANY, N.J., November 19, 2024--Zoetis Inc. (NYSE:ZTS) will participate in the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December 3, 2024. Wetteny Joseph, Executive Vice President and Chief Financial Officer, will represent the company and respond to questions from analysts at 11:30 a.m. ET.
Yahoo
Key Insights Using the 2 Stage Free Cash Flow to Equity, Zoetis fair value estimate is US$247 Zoetis is estimated to be...
Yahoo
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
SeekingAlpha
Zoetis, a leading animal health company, has shown impressive growth with a 17.55% CAGR since its IPO. Read why I rate ZTS stock a Buy now.
Yahoo
Insight into the Fund's Latest Portfolio Adjustments and Key Stock Performances
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.